Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$113,716
in 1 filing, $114K under 10b5-1 plans

Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Podlesak Dennis −$114K Director sold 3% of stake

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-07-04 Metzger Michael A President and COO Grant or award · Stock Option (Right to Buy) +200,000 200,000
2019-06-10 Podlesak Dennis Director Grant or award · Stock Option (Right to Buy) +44,000 44,000
2019-06-10 Meury William Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2019-06-10 Legault Pierre Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2019-06-10 Katkin Keith Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2019-06-10 Jarrett Jennifer Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2019-06-10 Egros Fabrice Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2019-05-13 Morrison Briggs Chief Executive Officer Purchase +7,200 $7.29 $53K 20,400
2019-05-09 Morrison Briggs Chief Executive Officer Purchase +13,200 $7.56 $100K 13,200
2019-03-21 Meyers Michael L. SVP, Chief Medical Officer Purchase +8 $4.87 $39 7,230
2019-03-21 Meyers Michael L. SVP, Chief Medical Officer Purchase +1,000 $4.93 $5K 7,118
2019-03-21 Meyers Michael L. SVP, Chief Medical Officer Purchase +104 $4.87 $506 7,222
2019-02-06 Ordentlich Peter Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2019-02-06 Morrison Briggs Chief Executive Officer Grant or award · Stock Option (Right to Buy) +354,000 354,000
2019-02-06 Shea Richard P Chief Financial Officer Grant or award · Stock Option (Right to Buy) +91,200 91,200
2019-02-06 Meyers Michael L. SVP, Chief Medical Officer Grant or award · Stock Option (Right to Buy) +104,325 104,325
2019-02-06 Metzger Michael A President and COO Grant or award · Stock Option (Right to Buy) +240,000 240,000
2019-01-31 Shea Richard P Chief Financial Officer Other acquisition +2,521 $4.76 $12K 4,215
2019-01-31 Meyers Michael L. SVP, Chief Medical Officer Other acquisition +3,720 $4.76 $18K 6,118
2019-01-31 Metzger Michael A President and COO Other acquisition +2,659 $4.76 $13K 2,659

Page 23 of 25 · 500 trades